CB-839: Phase I Triple Negative Breast Cancer Combination Data at the 2016 San Antonio Breast Cancer Symposium (SABCS). New data was ...
News
- Calithera Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Recent ...
- San Antonio biotech company clears major federal hurdle
CeloNova BioSciences Inc. cleared a critical hurdle that could expand its product portfolio in the U.S. The San Antonio-based biotech company ...
- Making the Grade for March 14
LUBBOCK -- Two Destination Imagination teams from Carver Center won first place at the regional competition Feb. 25 at Monterey High School in ...
- City of San Antonio Invests in bioAffinity Technologies
SAN ANTONIO, March 09, 2017 -- The San Antonio City Council today ... of the city's biotech community and a productive part of its vibrant economy.”.
- City of San Antonio Invests in bioAffinity Technologies
SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council ... a biotech company focused on the significant unmet need for non-invasive, ... “San Antonio is a world-class city that attracts exceptional talent.